Here, we show that within the glioma TME, treatment with IL-12 leads to a decreased proportion of CAR-T cells expressing high levels of PD1 and LAG3, inhibitory receptors which have been associated with reduced functional properties of CD8+ T cells31. This evidence concerns the gene LAG3 and central nervous system cancer.